Active, Not Recruiting
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
NCT06631079
- Conditions
- Solid Tumor
- Locations
-
- Charité Berlin, Germany
- NCT Heidelberg, Germany
- Comprehensive Cancer Center Munich, Germany
- National Cancer Center Vilnius, Lithuania